Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Association between SSRI Antidepressant Use and Reduced Risk of Intubation or Death in Hospitalized Patients with Coronavirus Disease 2019: a Multicenter Retrospective Observational Study

View ORCID ProfileNicolas Hoertel, Marina SANCHEZ RICO, Raphael VERNET, Nathanael BEEKER, Anne-Sophie JANNOT, Antoine NEURAZ, Elisa SALAMANCA, Nicolas PARIS, Christel DANIEL, Alexandre GRAMFORT, Guillaume LEMAITRE, Melodie BERNAUX, Ali BELLAMINE, Cedric LEMOGNE, Guillaume AIRAGNES, Anita BURGUN, Frederic LIMOSIN
doi: https://doi.org/10.1101/2020.07.09.20143339
Nicolas Hoertel
1 AP-HP ; Paris University ; INSERM ; Institut de Psychiatrie et Neurosciences de Paris.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nicolas Hoertel
  • For correspondence: nico.hoertel@yahoo.fr
Marina SANCHEZ RICO
2 Universidad Complutense de Madrid;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raphael VERNET
3 AP-HP;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathanael BEEKER
3 AP-HP;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne-Sophie JANNOT
3 AP-HP;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoine NEURAZ
3 AP-HP;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elisa SALAMANCA
3 AP-HP;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicolas PARIS
3 AP-HP;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christel DANIEL
3 AP-HP;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandre GRAMFORT
4 INRIA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillaume LEMAITRE
4 INRIA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melodie BERNAUX
3 AP-HP;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ali BELLAMINE
3 AP-HP;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cedric LEMOGNE
5 Paris University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillaume AIRAGNES
5 Paris University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anita BURGUN
3 AP-HP;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederic LIMOSIN
1 AP-HP ; Paris University ; INSERM ; Institut de Psychiatrie et Neurosciences de Paris.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: frederic.limosin@aphp.fr
  • Abstract
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective: To examine the association between antidepressant use and the risk of intubation or death in hospitalized patients with COVID-19. Design: Multicenter observational retrospective cohort study. Setting: Greater Paris University hospitals, France. Participants: 7,345 adults hospitalized with COVID-19 between 24 January and 1 April 2020, including 460 patients (6.3%) who received an antidepressant during the visit. Data source: Assistance Publique-Hopitaux de Paris Health Data Warehouse. Main outcome measures: The primary endpoint was a composite of intubation or death. We compared this endpoint between patients who received antidepressants and those who did not in time-to-event analyses adjusting for patient characteristics (such as age, sex, and comorbidities), disease severity and other psychotropic medications. The primary analyses were multivariable Cox models with inverse probability weighting. Results: Over a mean follow-up of 18.5 days (SD=27.1), 1,331 patients (18.1%) had a primary end-point event. Unadjusted hazard ratio estimates of the association between antidepressant use and the primary outcome stratified by age (i.e., 18-50, 51-70, 71-80, and 81+) were non-significant (all p>0.072), except in the group of patients aged 71-80 years (HR, 0.66; 95% CI, 0.45 to 0.98; p=0.041). Following adjustments, the primary analyses showed a significant association between use of any antidepressant (HR, 0.64; 95% CI, 0.51 to 0.80; p<0.001), SSRI (HR, 0.56; 95% CI, 0.42 to 0.75; p<0.001), and SNRI (HR, 0.57; 95% CI, 0.34 to 0.96; p=0.034), and reduced risk of intubation or death. Specifically, exposures to escitalopram, fluoxetine, and venlafaxine were significantly associated with lower risk of intubation or death (all p<0.05). These associations remain significant in multiple sensitivity analyses, except for the association between SNRI use and the outcome. Conclusions: SSRI use could be associated with lower risk of death or intubation in hospitalized patients with COVID-19. Double-blind controlled randomized clinical trials of these medications for COVID-19 are needed.

Competing Interest Statement

This work did not receive any external funding. NH has received personal fees and non-financial support from Lundbeck, outside the submitted work. FL has received speaker and consulting fees from Janssen-Cilag, Eutherapie-Servier, and Lundbeck, outside the submitted work. CL reports personal fees and non-financial support from Janssen-Cilag, Lundbeck, Otsuka Pharmaceutical, and Boehringer Ingelheim, outside the submitted work. GA reports personal fees from Pfizer, Pierre Fabre and Lundbeck, outside the submitted work. Other authors declare no competing interests.

Clinical Trial

NA

Funding Statement

This work did not receive any external funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This observational study using routinely collected data received approval from the Institutional Review Board of the AP-HP clinical data warehouse (decision CSE-20-20_COVID19, IRB00011591). AP-HP clinical Data Warehouse initiative ensures patients' information and informed consent regarding the different approved studies through a transparency portal in accordance with European Regulation on data protection and authorization number 1980120 from National Commission for Information Technology and Civil Liberties (CNIL). All procedures related to this work adhered to the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Supplemental analyses updated

Data Availability

Data from the AP-HP Health Data Warehouse can be obtained at https://eds.aphp.fr//.

https://eds.aphp.fr//.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted August 07, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Association between SSRI Antidepressant Use and Reduced Risk of Intubation or Death in Hospitalized Patients with Coronavirus Disease 2019: a Multicenter Retrospective Observational Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Association between SSRI Antidepressant Use and Reduced Risk of Intubation or Death in Hospitalized Patients with Coronavirus Disease 2019: a Multicenter Retrospective Observational Study
Nicolas Hoertel, Marina SANCHEZ RICO, Raphael VERNET, Nathanael BEEKER, Anne-Sophie JANNOT, Antoine NEURAZ, Elisa SALAMANCA, Nicolas PARIS, Christel DANIEL, Alexandre GRAMFORT, Guillaume LEMAITRE, Melodie BERNAUX, Ali BELLAMINE, Cedric LEMOGNE, Guillaume AIRAGNES, Anita BURGUN, Frederic LIMOSIN
medRxiv 2020.07.09.20143339; doi: https://doi.org/10.1101/2020.07.09.20143339
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Association between SSRI Antidepressant Use and Reduced Risk of Intubation or Death in Hospitalized Patients with Coronavirus Disease 2019: a Multicenter Retrospective Observational Study
Nicolas Hoertel, Marina SANCHEZ RICO, Raphael VERNET, Nathanael BEEKER, Anne-Sophie JANNOT, Antoine NEURAZ, Elisa SALAMANCA, Nicolas PARIS, Christel DANIEL, Alexandre GRAMFORT, Guillaume LEMAITRE, Melodie BERNAUX, Ali BELLAMINE, Cedric LEMOGNE, Guillaume AIRAGNES, Anita BURGUN, Frederic LIMOSIN
medRxiv 2020.07.09.20143339; doi: https://doi.org/10.1101/2020.07.09.20143339

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (142)
  • Anesthesia (46)
  • Cardiovascular Medicine (413)
  • Dentistry and Oral Medicine (69)
  • Dermatology (47)
  • Emergency Medicine (144)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (171)
  • Epidemiology (4851)
  • Forensic Medicine (3)
  • Gastroenterology (183)
  • Genetic and Genomic Medicine (675)
  • Geriatric Medicine (70)
  • Health Economics (192)
  • Health Informatics (627)
  • Health Policy (319)
  • Health Systems and Quality Improvement (203)
  • Hematology (85)
  • HIV/AIDS (156)
  • Infectious Diseases (except HIV/AIDS) (5330)
  • Intensive Care and Critical Care Medicine (329)
  • Medical Education (93)
  • Medical Ethics (25)
  • Nephrology (75)
  • Neurology (685)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (126)
  • Occupational and Environmental Health (206)
  • Oncology (439)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (89)
  • Pain Medicine (35)
  • Palliative Medicine (16)
  • Pathology (129)
  • Pediatrics (194)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (84)
  • Psychiatry and Clinical Psychology (780)
  • Public and Global Health (1811)
  • Radiology and Imaging (324)
  • Rehabilitation Medicine and Physical Therapy (138)
  • Respiratory Medicine (255)
  • Rheumatology (86)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (62)
  • Surgery (100)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (37)